Adverse metabolic effects of dietary fructose: Results from the recent epidemiological, clinical, and mechanistic studies

Kimber Stanhope, Jean Marc Schwarz, Peter J Havel

Research output: Contribution to journalArticle

114 Citations (Scopus)

Abstract

Purpose of review The effects of dietary sugar on risk factors and the processes associated with metabolic disease remain a controversial topic, with recent reviews of the available evidence arriving at widely discrepant conclusions. Recent findings There are many recently published epidemiological studies that provide evidence that sugar consumption is associated with metabolic disease. Three recent clinical studies, which investigated the effects of consuming relevant doses of sucrose or high-fructose corn syrup along with ad libitum diets, provide evidence that consumption of these sugars increase the risk factors for cardiovascular disease and metabolic syndrome. Mechanistic studies suggest that these effects result from the rapid hepatic metabolism of fructose catalyzed by fructokinase C, which generates substrate for de novo lipogenesis and leads to increased uric acid levels. Recent clinical studies investigating the effects of consuming less sugar, via educational interventions or by substitution of sugar-sweetened beverages for noncalorically sweetened beverages, provide evidence that such strategies have beneficial effects on risk factors for metabolic disease or on BMI in children. Summary The accumulating epidemiological evidence, direct clinical evidence, and the evidence suggesting plausible mechanisms support a role for sugar in the epidemics of metabolic syndrome, cardiovascular disease, and type 2 diabetes.

Original languageEnglish (US)
Pages (from-to)198-206
Number of pages9
JournalCurrent Opinion in Lipidology
Volume24
Issue number3
DOIs
StatePublished - Jun 2013

Fingerprint

Metabolic Diseases
Fructose
Beverages
fructokinase
Cardiovascular Diseases
Dietary Sucrose
Lipogenesis
Uric Acid
Type 2 Diabetes Mellitus
Sucrose
Epidemiologic Studies
Diet
Liver
Clinical Studies

Keywords

  • Fructose
  • High-fructose corn syrup
  • Metabolic disease
  • Sucrose
  • Sugar

ASJC Scopus subject areas

  • Cell Biology
  • Genetics
  • Molecular Biology
  • Cardiology and Cardiovascular Medicine
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Cite this

Adverse metabolic effects of dietary fructose : Results from the recent epidemiological, clinical, and mechanistic studies. / Stanhope, Kimber; Schwarz, Jean Marc; Havel, Peter J.

In: Current Opinion in Lipidology, Vol. 24, No. 3, 06.2013, p. 198-206.

Research output: Contribution to journalArticle

@article{02d2be7cffb348f4bab2a9b78f78e011,
title = "Adverse metabolic effects of dietary fructose: Results from the recent epidemiological, clinical, and mechanistic studies",
abstract = "Purpose of review The effects of dietary sugar on risk factors and the processes associated with metabolic disease remain a controversial topic, with recent reviews of the available evidence arriving at widely discrepant conclusions. Recent findings There are many recently published epidemiological studies that provide evidence that sugar consumption is associated with metabolic disease. Three recent clinical studies, which investigated the effects of consuming relevant doses of sucrose or high-fructose corn syrup along with ad libitum diets, provide evidence that consumption of these sugars increase the risk factors for cardiovascular disease and metabolic syndrome. Mechanistic studies suggest that these effects result from the rapid hepatic metabolism of fructose catalyzed by fructokinase C, which generates substrate for de novo lipogenesis and leads to increased uric acid levels. Recent clinical studies investigating the effects of consuming less sugar, via educational interventions or by substitution of sugar-sweetened beverages for noncalorically sweetened beverages, provide evidence that such strategies have beneficial effects on risk factors for metabolic disease or on BMI in children. Summary The accumulating epidemiological evidence, direct clinical evidence, and the evidence suggesting plausible mechanisms support a role for sugar in the epidemics of metabolic syndrome, cardiovascular disease, and type 2 diabetes.",
keywords = "Fructose, High-fructose corn syrup, Metabolic disease, Sucrose, Sugar",
author = "Kimber Stanhope and Schwarz, {Jean Marc} and Havel, {Peter J}",
year = "2013",
month = "6",
doi = "10.1097/MOL.0b013e3283613bca",
language = "English (US)",
volume = "24",
pages = "198--206",
journal = "Current Opinion in Lipidology",
issn = "0957-9672",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Adverse metabolic effects of dietary fructose

T2 - Results from the recent epidemiological, clinical, and mechanistic studies

AU - Stanhope, Kimber

AU - Schwarz, Jean Marc

AU - Havel, Peter J

PY - 2013/6

Y1 - 2013/6

N2 - Purpose of review The effects of dietary sugar on risk factors and the processes associated with metabolic disease remain a controversial topic, with recent reviews of the available evidence arriving at widely discrepant conclusions. Recent findings There are many recently published epidemiological studies that provide evidence that sugar consumption is associated with metabolic disease. Three recent clinical studies, which investigated the effects of consuming relevant doses of sucrose or high-fructose corn syrup along with ad libitum diets, provide evidence that consumption of these sugars increase the risk factors for cardiovascular disease and metabolic syndrome. Mechanistic studies suggest that these effects result from the rapid hepatic metabolism of fructose catalyzed by fructokinase C, which generates substrate for de novo lipogenesis and leads to increased uric acid levels. Recent clinical studies investigating the effects of consuming less sugar, via educational interventions or by substitution of sugar-sweetened beverages for noncalorically sweetened beverages, provide evidence that such strategies have beneficial effects on risk factors for metabolic disease or on BMI in children. Summary The accumulating epidemiological evidence, direct clinical evidence, and the evidence suggesting plausible mechanisms support a role for sugar in the epidemics of metabolic syndrome, cardiovascular disease, and type 2 diabetes.

AB - Purpose of review The effects of dietary sugar on risk factors and the processes associated with metabolic disease remain a controversial topic, with recent reviews of the available evidence arriving at widely discrepant conclusions. Recent findings There are many recently published epidemiological studies that provide evidence that sugar consumption is associated with metabolic disease. Three recent clinical studies, which investigated the effects of consuming relevant doses of sucrose or high-fructose corn syrup along with ad libitum diets, provide evidence that consumption of these sugars increase the risk factors for cardiovascular disease and metabolic syndrome. Mechanistic studies suggest that these effects result from the rapid hepatic metabolism of fructose catalyzed by fructokinase C, which generates substrate for de novo lipogenesis and leads to increased uric acid levels. Recent clinical studies investigating the effects of consuming less sugar, via educational interventions or by substitution of sugar-sweetened beverages for noncalorically sweetened beverages, provide evidence that such strategies have beneficial effects on risk factors for metabolic disease or on BMI in children. Summary The accumulating epidemiological evidence, direct clinical evidence, and the evidence suggesting plausible mechanisms support a role for sugar in the epidemics of metabolic syndrome, cardiovascular disease, and type 2 diabetes.

KW - Fructose

KW - High-fructose corn syrup

KW - Metabolic disease

KW - Sucrose

KW - Sugar

UR - http://www.scopus.com/inward/record.url?scp=84880131754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880131754&partnerID=8YFLogxK

U2 - 10.1097/MOL.0b013e3283613bca

DO - 10.1097/MOL.0b013e3283613bca

M3 - Article

C2 - 23594708

AN - SCOPUS:84880131754

VL - 24

SP - 198

EP - 206

JO - Current Opinion in Lipidology

JF - Current Opinion in Lipidology

SN - 0957-9672

IS - 3

ER -